Terms: = Prostate cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468
22 results:
1. Novel two-tiered screening approach identifies synergistic combinations of natural compounds for prostate cancer prevention and treatment.
Friedman CA; Saha A; Lavender Hackman G; Lu X; Lodi A; Tiziani S; DiGiovanni J
Mol Carcinog; 2024 Apr; 63(4):589-600. PubMed ID: 38197430
[TBL] [Abstract] [Full Text] [Related]
2. The role of inflammatory processes and zinc levels in prostatic enlargement among Iraqi samples.
Sameen AM; Shabeeb IA; Rashied RM
J Med Life; 2023 Sep; 16(9):1388-1392. PubMed ID: 38107701
[TBL] [Abstract] [Full Text] [Related]
3. Inflammatory markers in women with reported benign gynecologic pathology: an analysis of the prostate, Lung, Colorectal and Ovarian cancer Screening Trial.
King LA; Wentzensen N; Purdue MP; Katki HA; Pinto LA; Trabert B
Ann Epidemiol; 2022 Apr; 68():1-8. PubMed ID: 34906633
[TBL] [Abstract] [Full Text] [Related]
4. Preclinical development of CD126 CAR-T cells with broad antitumor activity.
Mishra AK; Kemler I; Dingli D
Blood Cancer J; 2021 Jan; 11(1):3. PubMed ID: 33414408
[TBL] [Abstract] [Full Text] [Related]
5. Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer.
Mahira S; Kommineni N; Husain GM; Khan W
Biomed Pharmacother; 2019 Feb; 110():803-817. PubMed ID: 30554119
[TBL] [Abstract] [Full Text] [Related]
6. The human oncogene SCL/TAL1 interrupting locus (stil) promotes tumor growth through MAPK/ERK, PI3K/Akt and AMPK pathways in prostate cancer.
Wu X; Xiao Y; Yan W; Ji Z; Zheng G
Gene; 2019 Feb; 686():220-227. PubMed ID: 30453068
[TBL] [Abstract] [Full Text] [Related]
7. Molecular correlates in urine for the obesity and prostatic inflammation of BPH/LUTS patients.
Tyagi P; Motley SS; Koyama T; Kashyap M; Gingrich J; Yoshimura N; Fowke JH
Prostate; 2018 Jan; 78(1):17-24. PubMed ID: 29080225
[TBL] [Abstract] [Full Text] [Related]
8. Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States.
Van Dyke AL; Lang Kuhs KA; Shiels MS; Koshiol J; Trabert B; Loftfield E; Purdue MP; Wentzensen N; Pfeiffer RM; Katki HA; Hildesheim A; Kemp TJ; Pinto LA; Chaturvedi AK; Safaeian M
PLoS One; 2017; 12(7):e0182359. PubMed ID: 28753646
[TBL] [Abstract] [Full Text] [Related]
9. Quantitative analysis of prostate specific antigen isoforms using immunoprecipitation and stable isotope labeling mass spectrometry.
Chen YT; Tuan LP; Chen HW; Wei IA; Chou MY; Chen HM; Tyan YC; Chen SF
Anal Chem; 2015 Jan; 87(1):545-53. PubMed ID: 25427836
[TBL] [Abstract] [Full Text] [Related]
10. Interleukin 8 and the male genital tract.
Lotti F; Maggi M
J Reprod Immunol; 2013 Nov; 100(1):54-65. PubMed ID: 23611586
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of prostate cancer (LNCaP) cell proliferation by volatile components from Nagami kumquats.
Jayaprakasha GK; Murthy KN; Demarais R; Patil BS
Planta Med; 2012 Jun; 78(10):974-80. PubMed ID: 22673830
[TBL] [Abstract] [Full Text] [Related]
12. Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading.
Terracciano D; Bruzzese D; Ferro M; Mazzarella C; Di Lorenzo G; Altieri V; Mariano A; Macchia V; Di Carlo A
Prostate; 2012 Jan; 72(1):100-7. PubMed ID: 21520165
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of IL-6 in localized prostatic cancer.
Alcover J; Filella X; Luqué P; Molina R; Izquierdo L; Augé JM; Alcaraz A
Anticancer Res; 2010 Oct; 30(10):4369-72. PubMed ID: 21036766
[TBL] [Abstract] [Full Text] [Related]
14. Lentivirus-mediated SMO RNA interference inhibits SMO expression and cell proliferation, and affects the cell cycle in LNCaP and PC3 cancer cell lines.
Yang B; Sun HY; Chen WH; Wen JL; Shi XT; Wang YM
Asian J Androl; 2010 Mar; 12(2):196-202. PubMed ID: 20023691
[TBL] [Abstract] [Full Text] [Related]
15. Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells.
Santer FR; Malinowska K; Culig Z; Cavarretta IT
Endocr Relat Cancer; 2010 Mar; 17(1):241-53. PubMed ID: 19966016
[TBL] [Abstract] [Full Text] [Related]
16. The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.
Morrissey C; Lai JS; Brown LG; Wang YC; Roudier MP; Coleman IM; Gulati R; Vakar-Lopez F; True LD; Corey E; Nelson PS; Vessella RL
Prostate; 2010 Mar; 70(4):412-24. PubMed ID: 19866469
[TBL] [Abstract] [Full Text] [Related]
17. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.
Shariat SF; Karam JA; Walz J; Roehrborn CG; Montorsi F; Margulis V; Saad F; Slawin KM; Karakiewicz PI
Clin Cancer Res; 2008 Jun; 14(12):3785-91. PubMed ID: 18559597
[TBL] [Abstract] [Full Text] [Related]
18. The relationship between testosterone and molecular markers of inflammation in older men.
Maggio M; Basaria S; Ceda GP; Ble A; Ling SM; Bandinelli S; Valenti G; Ferrucci L
J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):116-9. PubMed ID: 16760639
[TBL] [Abstract] [Full Text] [Related]
19. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix.
Wu X; Tortolero-Luna G; Zhao H; Phatak D; Spitz MR; Follen M
Clin Cancer Res; 2003 Aug; 9(9):3356-61. PubMed ID: 12960122
[TBL] [Abstract] [Full Text] [Related]
20. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer.
Salgado R; Junius S; Benoy I; Van Dam P; Vermeulen P; Van Marck E; Huget P; Dirix LY
Int J Cancer; 2003 Feb; 103(5):642-6. PubMed ID: 12494472
[TBL] [Abstract] [Full Text] [Related]
[Next]
